Autonomic Nervous System

Chapter 18: Adrenergic Drugs

Overview

  • Adrenergic Drugs: These are pharmacological agents that stimulate the sympathetic nervous system (SNS), also referred to as adrenergic agonists or sympathomimetics. They play a critical role in the body’s response to stress and emergency situations by mimicking the effects of naturally occurring catecholamines such as norepinephrine (NE), epinephrine (EPI), and dopamine (DA).

Nervous System Structure

  • Central Nervous System (CNS): Comprising the brain and spinal cord, the CNS is the control center for the body, processing and relaying information.

  • Peripheral Nervous System (PNS): Divided into two primary components:

    • Somatic Nervous System: Controls voluntary skeletal muscles.

    • Autonomic Nervous System: Regulates involuntary functions and is further divided into:

      • Parasympathetic Nervous System: Often referred to as the "rest and digest" system, it conserves energy and promotes maintenance activities.

      • Sympathetic Nervous System: Often termed the "fight or flight" system, it prepares the body for action in times of stress by increasing heart rate, dilating pupils, and inhibiting non-essential functions.

Receptor Types

  • Adrenergic Receptors: These are specialized receptors primarily responsive to catecholamines.

    • Alpha Receptors:

      • Alpha 1: Responsible for vasoconstriction and increased peripheral resistance.

      • Alpha 2: Functions as an inhibitory receptor, decreasing neurotransmitter release and reducing sympathetic outflow.

    • Beta Receptors:

      • Beta 1: Primarily located in the heart, influencing heart rate and contractility.

      • Beta 2: Found mainly in the smooth muscle of bronchioles, promoting bronchodilation and vasodilation in skeletal muscles.

      • Beta 3: Involved in lipolysis and thermogenesis in adipose tissue.

    • Dopaminergic Receptors: Respond specifically to dopamine, leading to vasodilation in renal and other vascular territories.

Responses to Alpha and Beta Stimulation

  • Alpha 1 Stimulated Effects:

    • It induces vasoconstriction, leading to increased blood pressure.

    • Promotes contraction of smooth muscles in various organs including the bladder sphincter, enhancing urinary retention.

  • Alpha 2 Stimulated Effects:

    • Inhibits the release of norepinephrine in the CNS, leading to reduced sympathetic activity, decreased heart rate (HR), and lower blood pressure (BP).

  • Beta 1 Receptor Location:

    • Primarily found in the heart, stimulation increases heart rate, myocardial contractility, and conduction velocity, which is crucial during emergencies.

  • Beta 2 Receptor Location:

    • Located in smooth muscles of bronchioles, stimulants cause relaxation leading to bronchodilation, critical in conditions like asthma.

    • Also engages processes like glycogenolysis, providing energy during stress.

  • Dopaminergic Receptor Effects:

    • Dilation of renal, mesenteric, coronary, and cerebral blood vessels, significantly enhancing blood flow during high demand periods.

SNS Stimulation Response

  • The SNS activation, commonly known as the "Fight or Flight" response, prepares the body to cope with stress. Key responses include:

    • Dilating pupils for enhanced vision.

    • Inhibiting salivation to divert energy elsewhere.

    • Accelerating heart rate and increasing bronchial dilation for oxygen intake.

Receptors and their Responses

  • Cardiovascular Reactions:

    • Alpha 1: Induces vasoconstriction, elevating blood pressure.

    • Beta 1: Enhances cardiac contractility and heart rate, crucial for emergency responses.

    • Beta 2: Induces vasodilation in certain vascular beds.

  • Gastrointestinal Reactions:

    • Beta 2 and Alpha 1: Decreases gastrointestinal motility, conserving energy for the priorities of the fight-or-flight response.

Drug Types and Mechanisms

  • Direct-Acting Sympathomimetics: Medications that bind directly to adrenergic receptors to elicit physiological responses; examples include epinephrine and norepinephrine.

  • Indirect-Acting Sympathomimetics: These drugs lead to the release of catecholamines from storage vesicles, enhancing effects without direct receptor binding; examples include amphetamines.

  • Mixed-Action Sympathomimetics: Combine both direct and indirect mechanisms for a comprehensive effect on the sympathetic system; examples include ephedrine.

Effects of Stimulation

  • Alpha 1 Agonists (e.g., phenylephrine): Indications include treating nasal congestion and managing hypotension. They lead to pupillary dilation and bladder sphincter contraction.

  • Beta 1 Agonists: Used primarily to increase myocardial contractility and heart rate, beneficial in acute heart failure situations.

  • Beta 2 Agonists (e.g., albuterol): Promotes bronchodilation and relaxation of uterine muscles, indicated in asthma and bronchitis treatment.

Vasoactive Sympathomimetics**:

  • Medications like dobutamine, ephedrine, and dopamine play a key role in supporting cardiac function during instances of heart failure or shock by targeting specific adrenergic receptors and enhancing myocardial performance.

Adverse Effects of Adrenergic Agonists

  • CNS Effects: Including symptoms like headache, restlessness, excitement, and insomnia which may occur due to overstimulation.

  • Cardiovascular Effects: Such as palpitations, tachycardia, and hypertension due to exaggerated responsiveness of the heart and blood vessels.

  • Other Effects: Include dry mouth, appetite loss, and potential for anxiety or tremors.

Nursing Implications

  • Comprehensive assessment including past medical history, allergies, and current medications is essential.

  • Continuous monitoring for both therapeutic and adverse effects is crucial post-administration of adrenergic drugs to mitigate potential risks. Consideration of drug interactions is paramount for patient safety.